Venom Peptides: Improving Specificity in Cancer Therapy
COXIV, mitochondrial respiratory chain complex IV
While the RNI for maintenance is only 1.5 g daily, therapeutic oral doses typically range from: 50-150 g daily for mild deficiency prevention in at-risk groups 1,000-2,000 g daily for treating confirmed deficiency without malabsorption Some formulations contain up to 5,000 g, though there is no proven additional benefit over 1,000-2,000 g for most patients The reason for this dosage discrepancy lies in absorption efficiency
Studies from labs reveal that NAD has an impact on sirtuins, helps keep mitochondria strong, and assists the body in handling oxidative stress
We also care for patients whose hypothyroidism is caused by certain medications or pituitary gland disorders
AMPK and mTOR in cellular energy homeostasis and drug targets